Literature DB >> 33745234

Point-of-care testing can achieve same-day diagnosis for infants and rapid ART initiation: results from government programmes across six African countries.

Caroline E Boeke1, Jessica Joseph1, Melody Wang1, Zelalem M Abate2, Charles Atem3, Khady Diatou Coulibaly4, Adisu Kebede5, Brianán Kiernan6, Leonard Kingwara7,8, Phibeon Mangwendeza9, Tatenda Maparo9, Rose Nadege Mbaye6, Solomon Mukungunugwa10, Catherine Ngugi8, Divine Nzuobontane3, Marie Claire Okomo Assoumou11, Yemsirach Reta5, Barbara Wambugu8, Maria R Rioja1, Trevor Peter1, Naoko Doi1, Lara Vojnov1, Shaukat Khan1, Jilian A Sacks1.   

Abstract

INTRODUCTION: Point-of-care (POC) early infant diagnosis (EID) testing has been shown to dramatically decrease turnaround times from sample collection to caregiver result receipt and time to ART initiation for HIV-positive infants compared to centralized laboratory testing. As governments in sub-Saharan Africa implement POC EID technologies, we report on the feasibility and effectiveness of POC EID testing and the impact of same-day result delivery on rapid ART initiation within national programmes across six countries.
METHODS: This pre-/post-evaluation compared centralized laboratory-based (pre) with POC (post) EID testing in 52 facilities across Cameroon, Democratic Republic of Congo, Ethiopia, Kenya, Senegal and Zimbabwe between April 2017 and October 2019 (country-dependent). Data were collected retrospectively from routine records at health facilities for all infants tested under two years of age. Hazard ratios and 95% confidence intervals were calculated to compare time-to-event outcomes, visualized with Kaplan-Meier curves, and the Somers' D test was used to compare continuous outcomes.
RESULTS: Data were collected for 2892 EID tests conducted on centralized laboratory-based platforms and 4610 EID tests on POC devices with 127 (4%) and 192 (4%) HIV-positive infants identified, respectively. POC EID significantly reduced the time from sample collection to caregiver result receipt (POC median: 0 days, IQR: 0 to 0 vs. centralized: 35 days, IQR: 26 to 56) and time from sample collection to ART initiation for HIV-positive infants (POC median: 1 day, IQR: 0 to 7 vs. centralized: 39 days, IQR: 26 to 57). With POC testing, 72% of infants received results on the same day as sample collection; HIV-positive infants with a same-day diagnosis had six times the rate of ART initiation compared to those diagnosed one or more days after sample collection (HR: 6.39; 95% CI: 3.44 to 11.85).
CONCLUSIONS: Same-day diagnosis and treatment initiation for infants is possible with POC EID within routine government-led and -supported public sector healthcare facilities in resource-limited settings. Given that POC EID allows for rapid ART initiation, aligning to the World Health Organization's recommendation of ART initiation within seven days, its use in public sector programmes has the potential to reduce overall mortality for infants with HIV through early treatment initiation.
© 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Entities:  

Keywords:  ART initiation; Africa; early infant diagnosis; point of care; turnaround times

Year:  2021        PMID: 33745234      PMCID: PMC7981587          DOI: 10.1002/jia2.25677

Source DB:  PubMed          Journal:  J Int AIDS Soc        ISSN: 1758-2652            Impact factor:   5.396


  17 in total

1.  Acceptability of Routine Point-of-Care Early Infant Diagnosis in Eight African Countries: Findings From a Qualitative Assessment of Clinical and Laboratory Personnel.

Authors:  Flavia Bianchi; Sara Clemens; Zainab Arif; Emma Sacks; Jennifer Cohn
Journal:  J Acquir Immune Defic Syndr       Date:  2020-07-01       Impact factor: 3.731

2.  Accurate early infant HIV diagnosis in primary health clinics using a point-of-care nucleic acid test.

Authors:  Ilesh V Jani; Bindiya Meggi; Nédio Mabunda; Adolfo Vubil; Nadia E Sitoe; Ocean Tobaiwa; Jorge I Quevedo; Jonathan D Lehe; Osvaldo Loquiha; Lara Vojnov; Trevor F Peter
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

3.  Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial.

Authors:  Gideon Amanyire; Fred C Semitala; Jennifer Namusobya; Richard Katuramu; Leatitia Kampiire; Jeanna Wallenta; Edwin Charlebois; Carol Camlin; James Kahn; Wei Chang; David Glidden; Moses Kamya; Diane Havlir; Elvin Geng
Journal:  Lancet HIV       Date:  2016-08-27       Impact factor: 12.767

4.  Effect of point-of-care early infant diagnosis on antiretroviral therapy initiation and retention of patients.

Authors:  Ilesh V Jani; Bindiya Meggi; Osvaldo Loquiha; Ocean Tobaiwa; Chishamiso Mudenyanga; Alcina Zitha; Dadirayi Mutsaka; Nedio Mabunda; Adolfo Vubil; Timothy Bollinger; Lara Vojnov; Trevor F Peter
Journal:  AIDS       Date:  2018-07-17       Impact factor: 4.177

Review 5.  Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review.

Authors:  Sydney Rosen; Matthew P Fox
Journal:  PLoS Med       Date:  2011-07-19       Impact factor: 11.069

6.  Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.

Authors:  Sydney Rosen; Mhairi Maskew; Matthew P Fox; Cynthia Nyoni; Constance Mongwenyana; Given Malete; Ian Sanne; Dorah Bokaba; Celeste Sauls; Julia Rohr; Lawrence Long
Journal:  PLoS Med       Date:  2016-05-10       Impact factor: 11.069

7.  Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe.

Authors:  Zibusiso Ndlovu; Emmanuel Fajardo; Elton Mbofana; Tatenda Maparo; Daniela Garone; Carol Metcalf; Helen Bygrave; Kekeletso Kao; Sekesai Zinyowera
Journal:  PLoS One       Date:  2018-03-02       Impact factor: 3.240

8.  Programmatic evaluation of feasibility and efficiency of at birth and 6-week, point of care HIV testing in Kenyan infant.

Authors:  Catherine Wexler; Niaman Nazir; May Maloba; Melinda Brown; Kathy Goggin; Brad Gautney; Nicodemus Maosa; Shadrack Babu; Elizabeth Muchoki; Natabhona Mabachi; Raphael Lwembe; Sarah Finocchario-Kessler
Journal:  PLoS One       Date:  2020-10-09       Impact factor: 3.240

9.  Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis.

Authors:  Nicole C McCann; Jennifer Cohn; Clare Flanagan; Emma Sacks; Sushant Mukherjee; Rochelle P Walensky; Oluwarantimi Adetunji; Kenneth K Maeka; Christopher Panella; Addmore Chadambuka; Haurovi Mafaune; Collins Odhiambo; Kenneth A Freedberg; Andrea L Ciaranello
Journal:  J Acquir Immune Defic Syndr       Date:  2020-07-01       Impact factor: 3.771

10.  A tutorial on frailty models.

Authors:  Theodor A Balan; Hein Putter
Journal:  Stat Methods Med Res       Date:  2020-05-28       Impact factor: 3.021

View more
  4 in total

1.  The NSEBA Demonstration Project: implementation of a point-of-care platform for early infant diagnosis of HIV in rural Zambia.

Authors:  Catherine G Sutcliffe; Nkumbula Moyo; Jessica L Schue; Jane N Mutanga; Mutinta Hamahuwa; Passwell Munachoonga; Sylvia Maunga; Philip E Thuma; William J Moss
Journal:  Trop Med Int Health       Date:  2021-06-07       Impact factor: 3.918

Review 2.  Costs and cost-effectiveness of HIV early infant diagnosis in low- and middle-income countries: a scoping review.

Authors:  Kira Elsbernd; Karl M F Emmert-Fees; Amanda Erbe; Veronica Ottobrino; Arne Kroidl; Till Bärnighausen; Benjamin P Geisler; Stefan Kohler
Journal:  Infect Dis Poverty       Date:  2022-07-15       Impact factor: 10.485

3.  Delays in HIV-1 infant polymerase chain reaction testing may leave children without confirmed diagnoses in the Western Cape province, South Africa.

Authors:  Kamela L Mahlakwane; Wolfgang Preiser; Nokwazi Nkosi; Nasheen Naidoo; Gert van Zyl
Journal:  Afr J Lab Med       Date:  2022-06-23

4.  Same-day test and treat for infants with HIV infection: finally within reach.

Authors:  Lara Vojnov; Diane Havlir; Landon Myer; Elaine Abrams; Ilesh Jani
Journal:  J Int AIDS Soc       Date:  2022-09       Impact factor: 6.707

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.